NCT03578146View on ClinicalTrials.gov

Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 2 of 4)

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Healthy Volunteers
Interventions
COMBINATION_PRODUCT

PRT064445/Rivaroxaban

COMBINATION_PRODUCT

Placebo/Rivaroxaban

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Portola Pharmaceuticals

INDUSTRY

NCT03578146 - Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 2 of 4) | Biotech Hunter | Biotech Hunter